High-intensity resistance training attenuates dexamethasone-induced muscle atrophy

被引:31
作者
Krug, Andre L. O. [1 ]
Macedo, Anderson G. [1 ]
Zago, Anderson S. [2 ]
Rush, James W. E. [3 ]
Santos, Carlos F. [4 ]
Amaral, Sandra L. [1 ,2 ]
机构
[1] Sao Paulo State Univ, Univ Fed Sao Carlos, PIPGCF UFscar UNESP, Joint Grad Program Physiol Sci, Sao Paulo, Brazil
[2] Sao Paulo State Univ, Fac Sci, Dept Phys Educ, Ave Eng Luiz Edmundo Carrijo Coube, Sao Paulo, Brazil
[3] Univ Waterloo, Dept Kinesiol, Fac Appl Hlth Sci, Waterloo, ON N2L 3G1, Canada
[4] Univ Sao Paulo, Dept Biol Sci, Bauru Sch Dent, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
glucocorticoids; ladder climbing; muscle atrophy; resistance training; skeletal muscle; INSULIN-RESISTANCE; EXPRESSION; EXERCISE; ATROGIN-1; GLUCOCORTICOIDS; HYPERTROPHY; SARCOPENIA; LEPTIN; GROWTH; MURF1;
D O I
10.1002/mus.24906
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionIn this study we investigated the effects of high-intensity resistance training (RT) on dexamethasone (DEX)-induced muscle atrophy in flexor hallucis longus (FHL), tibialis anterior (TA), and soleus (SOL) muscles. Methods: Rats underwent either high-intensity RT or were kept sedentary. In the last 10 days they received either DEX (0.5mg/kg/day, intraperitoneally) or saline. Results: DEX reduced body weight (-21%), food intake (-28%), FHL and TA muscle mass (-20% and -18%, respectively), and increased muscle-specific ring finger 1 (MuRF-1) protein level (+37% and +45.5%). RT attenuated FHL muscle atrophy through a combination of low increase in MuRF-1 protein level (-3.5%) and significant increases in mammalian target of rapamycin (mTOR) (+63%) and p70S6K (+46% and +49% for control and DEX, respectively) protein levels. Conclusion: RT attenuated DEX-induced muscle atrophy through a combination of increases in mTOR and p70S6K protein levels and a low increase in MuRF-1 protein level. Muscle Nerve53: 779-788, 2016
引用
收藏
页码:779 / 788
页数:10
相关论文
共 40 条
  • [1] Regulation of type IV collagen gene expression and degradation in fast and slow muscles during dexamethasone treatment and exercise
    Ahtikoski, AM
    Riso, EM
    Koskinen, SOA
    Risteli, J
    Takala, TES
    [J]. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2004, 448 (01): : 123 - 130
  • [2] Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1-dependent mechanism
    Alamdari, Nima
    Aversa, Zaira
    Castillero, Estibaliz
    Gurav, Aniket
    Petkova, Victoria
    Tizio, Steven
    Hasselgren, Per-Olof
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 417 (01) : 528 - 533
  • [3] Angiotensin II and VEGF are involved in angiogenesis induced by short-term exercise training
    Amaral, SL
    Papanek, PE
    Greene, AS
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (03): : H1163 - H1169
  • [4] Auclair D, 1997, AM J PHYSIOL-CELL PH, V272, pC1007
  • [5] Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids
    Baehr, Leslie M.
    Furlow, J. David
    Bodine, Sue C.
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2011, 589 (19): : 4759 - 4776
  • [6] Exercise training prevents hyperinsulinemia, muscular glycogen loss and muscle atrophy induced by dexamethasone treatment
    Barel, Matheus
    Brogin Perez, Otavio Andre
    Giozzet, Vanessa Aparecida
    Rafacho, Alex
    Bosqueiro, Jose Roberto
    do Amaral, Sandra Lia
    [J]. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2010, 108 (05) : 999 - 1007
  • [7] Identification of ubiquitin ligases required for skeletal muscle atrophy
    Bodine, SC
    Latres, E
    Baumhueter, S
    Lai, VKM
    Nunez, L
    Clarke, BA
    Poueymirou, WT
    Panaro, FJ
    Na, EQ
    Dharmarajan, K
    Pan, ZQ
    Valenzuela, DM
    DeChiara, TM
    Stitt, TN
    Yancopoulos, GD
    Glass, DJ
    [J]. SCIENCE, 2001, 294 (5547) : 1704 - 1708
  • [8] Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes
    Castillero, Estibaliz
    Alamdari, Nima
    Lecker, Stewart H.
    Hasselgren, Per-Olof
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (10): : 1495 - 1502
  • [9] Time course expression of Foxo transcription factors in skeletal muscle following corticosteroid administration
    Cho, John E.
    Fournier, Mario
    Da, Xiaoyu
    Lewis, Michael I.
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2010, 108 (01) : 137 - 145
  • [10] MYOSIN HEAVY-CHAIN TURNOVER AND GLUCOCORTICOID DETERRENCE BY EXERCISE IN MUSCLE
    CZERWINSKI, SM
    ZAK, R
    KUROWSKI, TT
    FALDUTO, MT
    HICKSON, RC
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 1989, 67 (06) : 2311 - 2315